Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Moderate to Severe Patch Type Alopecia Areata
NCT02018042Phase 2Completed
- Sponsor
- Columbia University
- Start
- Sep 2013
- Primary completion
- Jul 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in alopecia areata, sponsored by Columbia University. Started Sep 2013; status: completed.
02
Drugs
abatacept
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT02018042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018042.